ONEMEDNET CORPORATION Effective Tax Rate
ONEMEDNET CORPORATION (ONMD) reported Effective Tax Rate of 0.00% for the 12-month period ending 2025-12-31, per its S-1/A filed 2026-07-08.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-07-08
- ONEMEDNET CORPORATION effective income tax rate reconciliation, percent for the quarter ending 2023-09-30 was 12.03%, a 94.75% decline year-over-year.
- ONEMEDNET CORPORATION effective income tax rate reconciliation, percent for the quarter ending 2023-06-30 was 108.96%.
- ONEMEDNET CORPORATION effective income tax rate reconciliation, percent for the quarter ending 2023-03-31 was -225.88%, a 679.77% decline year-over-year.
- ONEMEDNET CORPORATION effective income tax rate reconciliation, percent for the quarter ending 2022-09-30 was 229.26%.
- ONEMEDNET CORPORATION effective income tax rate reconciliation, percent for fiscal 2023 was -0.10%.
- ONEMEDNET CORPORATION effective income tax rate reconciliation, percent for fiscal 2022 was -0.10%.
| Period end | Effective Income Tax Rate Reconciliation, Percent 1 month | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 3 month as first filed | Effective Income Tax Rate Reconciliation, Percent 6 month | Effective Income Tax Rate Reconciliation, Percent 9 month | Effective Income Tax Rate Reconciliation, Percent 12 month | Effective Income Tax Rate Reconciliation, Percent 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | 0.00% S-1/A · filed 2026-07-08 | ||||||
| 2024-12-31 | 0.00% S-1/A · filed 2026-07-08 | ||||||
| 2023-12-31 | -0.10% 10-K · filed 2025-04-15 | ||||||
| 2023-09-30 | 12.03% 10-Q/A · filed 2023-12-18 | 30.10% 10-Q/A · filed 2023-12-18 | |||||
| 2023-06-30 | 108.96% 10-Q · filed 2023-08-14 | 392.45% 10-Q · filed 2023-08-14 | |||||
| 2023-03-31 | -225.88% 10-Q · filed 2023-05-19 | ||||||
| 2022-12-31 | -0.10% 10-K/A · filed 2024-11-05 | -38.96% 10-K · filed 2023-03-31 | |||||
| 2022-09-30 | 229.26% 10-Q/A · filed 2023-12-18 | -220.93% 10-Q · filed 2022-11-18 | 3.44% 10-Q/A · filed 2023-12-18 | ||||
| 2022-06-30 | 0.00% 10-Q · filed 2023-08-14 | 0.00% 10-Q · filed 2023-08-14 | |||||
| 2022-03-31 | 38.96% 10-Q · filed 2023-05-19 | ||||||
| 2021-09-30 | 0.00% 10-Q · filed 2022-11-18 | 0.00% 10-Q · filed 2022-11-18 | |||||
| 2021-03-31 | 0.00% 10-Q · filed 2022-11-18 | ||||||
| 2021-02-28 | 0.00% 10-Q · filed 2022-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |